These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 20921836)
1. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans. De Andrés J; Adsuara VM; Palmisani S; Villanueva V; López-Alarcón MD Reg Anesth Pain Med; 2010; 35(3):255-60. PubMed ID: 20921836 [TBL] [Abstract][Full Text] [Related]
2. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199 [TBL] [Abstract][Full Text] [Related]
3. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study. Seo HG; Bang MS; Chung SG; Jung SH; Lee SU Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438 [TBL] [Abstract][Full Text] [Related]
4. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Porta M Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608 [TBL] [Abstract][Full Text] [Related]
5. Use of botulinum toxin in the treatment of chronic myofascial pain. De Andrés J; Cerda-Olmedo G; Valía JC; Monsalve V; Lopez-Alarcón ; Minguez A Clin J Pain; 2003; 19(4):269-75. PubMed ID: 12840622 [TBL] [Abstract][Full Text] [Related]
6. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial. Ojala T; Arokoski JP; Partanen J Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597 [TBL] [Abstract][Full Text] [Related]
7. An update on botulinum toxin A injections of trigger points for myofascial pain. Zhou JY; Wang D Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study. Graboski CL; Gray DS; Burnham RS Pain; 2005 Nov; 118(1-2):170-5. PubMed ID: 16202527 [TBL] [Abstract][Full Text] [Related]
9. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections? Benecke R; Heinze A; Reichel G; Hefter H; Göbel H; Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970 [TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Wheeler AH; Goolkasian P; Gretz SS Spine (Phila Pa 1976); 1998 Aug; 23(15):1662-6; discussion 1667. PubMed ID: 9704373 [TBL] [Abstract][Full Text] [Related]
11. Effect of Local Anesthetic Versus Botulinum Toxin-A Injections for Myofascial Pain Disorders: A Systematic Review and Meta-Analysis. Ahmed S; Subramaniam S; Sidhu K; Khattab S; Singh D; Babineau J; Kumbhare DA Clin J Pain; 2019 Apr; 35(4):353-367. PubMed ID: 30589660 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272 [TBL] [Abstract][Full Text] [Related]
13. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review. Lang AM Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study. Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design. Nicol AL; Wu II; Ferrante FM Anesth Analg; 2014 Jun; 118(6):1326-35. PubMed ID: 24842179 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism. Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209 [TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of PrabotulinumtoxinA (Nabota Kim DY; Kim JM Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30177597 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study. Lew HL; Lee EH; Castaneda A; Klima R; Date E Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Ernberg M; Hedenberg-Magnusson B; List T; Svensson P Pain; 2011 Sep; 152(9):1988-1996. PubMed ID: 21514731 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series. Baker JS; Nolan PJ J Am Dent Assoc; 2017 Jan; 148(1):33-39. PubMed ID: 28314397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]